Atliprofen methyl ester

Drug Profile

Atliprofen methyl ester

Alternative Names: IDPH 8261

Latest Information Update: 09 Aug 2002

Price : $50

At a glance

  • Originator Indian Drugs and Pharmaceuticals
  • Class Nonsteroidal anti-inflammatories
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Rheumatic disorders

Most Recent Events

  • 21 May 1997 IDPH 8261 is now called atliprofen methyl ester
  • 22 Aug 1996 A preclinical study has been added to the pharmacodynamics and side effects sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top